A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer (Q53984577)
scientific article
Language:
Current Data About A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer
(P31) (Q13442814)
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P50) (Q37392552)
(P1545) 1
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(Q107069384)
(P1545) 3
(P1932) Charles Erlichman
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P304) 5755-5763
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P407) (Q1860)

(P433) 19
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P478) 12
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P577) Sunday, October 1, 2006
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P921) (Q323936)
(P887)

(P1433) (Q332253)
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P1476) "A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancer" (language: en)
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

(P2093) Jan C Buckner
(P1545) 2
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Marilyn S Pollack
(P1545) 4
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Joseph P Boni
(P1545) 5
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Gary Dukart
(P1545) 6
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Bonnie Marshall
(P1545) 7
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Lisa Speicher
(P1545) 8
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Laurence Moore
(P1545) 9
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

Eric K Rowinsky
(P1545) 10
(P248)
(P698) 17020981
(P813) Wednesday, May 23, 2018
(P854) http://europepmc.org/abstract/MED/17020981

other details